Retrospective longitudinal analysis of cognition and clinical-behavioral parameters (PRO) in relapsing-remitting multiple sclerosis (RRMS) patients treated with Teriflunomide - results from a 12 month registry study in German practice centers
Document type:
Article
Author(s):
Schreiber, H; Rossnagel, F; Gosswein, KH; Braune, S; Bergmann, A